| Literature DB >> 33738615 |
Afnan Sedky Adly1,2, Aya Sedky Adly3,4, Mahmoud Sedky Adly5,6.
Abstract
Rheumatoid arthritis (RA) is a progressive common autoimmune disorder and is one of the most functional limiting diseases in elderly. Until recently, its treatment is mainly based on physical locations and meetings while being face to face. However, laser acupuncture tele-therapy approaches can significantly provide the patient with safety during the COVID-19 pandemic as well as changing the disorder's prognosis. Sixty patients were assigned randomly into 2 groups with 1:1 ratio. Patients in group A are treated remotely by laser acupuncture in addition to methotrexate and a tele-rehabilitation program in the form of aerobic exercise training. Patients in group B are treated by methotrexate and a tele-rehabilitation program in the form of aerobic exercise. There was a statistically significant difference in health assessment questionnaire (HAQ) pre- and post-treatment in group A (p < 0.05). The C-reactive protein (CRP) and interleukin-6 (IL-6) inflammatory markers as well as the malondialdehyde (MDA) oxidative marker showed a significant reduction pre- and post-treatment in group A (p < 0.05). Additionally, there was a significant increase in the adenosine tri-phosphate (ATP) antioxidant marker pre- and post-treatment in group A (p < 0.05). The comparison between groups A and B showed a statistically significant post-treatment difference in RAQoL, CRP, IL-6, ATP, and MDA in group A than group B. Considering the significant improvement that was found in the laser acupuncture group, it can be concluded that the use of laser acupuncture as adjunctive was effective in the treatment of elderly patients with RA. ClinicalTrials.gov Identifier: NCT04758689.Entities:
Keywords: Elderly; Geriatrics; Laser acupuncture; Rheumatoid arthritis; Tele-rehabilitation
Mesh:
Year: 2021 PMID: 33738615 PMCID: PMC7972942 DOI: 10.1007/s10103-021-03287-0
Source DB: PubMed Journal: Lasers Med Sci ISSN: 0268-8921 Impact factor: 2.555
Mean and SD (standard deviation) of patients age by groups
| Group | Age mean and SD |
|---|---|
| Group A | 68.87 ± 2.69 |
| Group B | 69.13 ± 2.89 |
| Total | 69 ± 2.8 |
Comparative analysis of the primary outcomes
| Primary outcomes | Tukey’s multiple comparison test | Mean difference | Significance ( |
|---|---|---|---|
| IL-6 | Group A (pre) vs group A (post) | 38.47 | * |
| Group A (pre) vs group B (pre) | −2.763 | ns | |
| Group A (post) vs group B (post) | −41.00 | * | |
| Group B (pre) vs group B (post) | 0.2267 | ns | |
| MDA | Group A (pre) vs group A (post) | 3.603 | *** |
| Group A (pre) vs group B (pre) | 0.1111 | ns | |
| Group A (post) vs group B (post) | −3.344 | *** | |
| Group B (pre) vs group B (post) | 0.1472 | ns | |
| ATP | Group A (pre) vs group A (post) | −44.52 | *** |
| Group A (pre) vs group B (pre) | −0.6655 | ns | |
| Group A (post) vs group B (post) | 39.53 | *** | |
| Group B (pre) vs group B (post) | −4.329 | ns | |
| CRP | Group A (pre) vs group A (post) | 37.26 | *** |
| Group A (pre) vs group B (pre) | 0.7527 | ns | |
| Group A (post) vs group B (post) | −34.68 | *** | |
| Group B (pre) vs group B (post) | 1.826 | ns |
ns not significant, p value ≥ 0.05
***Extremely significant, p value 0.0001 to 0.001
*Significant, p value 0.01 to 0.05
Comparative analysis of the secondary outcomes
| Secondary outcomes | Tukey’s multiple comparison test | Mean difference | Significance ( |
|---|---|---|---|
| RAQOL | Group A (pre) vs group A (post) | 2.733 | ns |
| Group A (pre) vs group B (pre) | −2.100 | ns | |
| Group A (post) vs group B (post) | −4.533 | ** | |
| Group B (pre) vs group B (post) | 0.3000 | Non-significant | |
| HAQ | Group A (pre) vs group A (post) | 0.2350 | * |
| Group A (pre) vs group B (pre) | 0.09167 | ns | |
| Group A (post) vs group B (post) | −0.09733 | ns | |
| Group B (pre) vs group B (post) | 0.0460 | ns |
ns not significant, p value ≥ 0.05
**Very significant, p value 0.001 to 0.01
*Significant, p value 0.01 to 0.05
Fig. 1Patients scores (ranged between 0 and 5, higher scores indicate better opinion)